Profound Medical PROF
NASDAQ PROF
$5.69 -0.23 (-3.89%)
At close: Oct 21, 2026 · 4:00 PM EDT

Profound Medical (PROF) EBITDA Margin (2024 - 2026)

Updated

Profound Medical (PROF) reported EBITDA Margin of -440.23% for Q2 2026, up 177.81 percentage points from -618.05% a year earlier but down 291.82 percentage points from the prior quarter.

Analysis

Profound Medical (PROF) EBITDA Margin (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Profound Medical's EBITDA Margin came in at -182.74%, up 168.26 percentage points year-over-year; for FY2025, it came in at -252.79%, up 48.02 percentage points from FY2024.

  • EBITDA Margin has increased for three consecutive years, with a five-year change of +0.65 percentage points (FY2020 to FY2025).
  • By year, EBITDA Margin came in at -300.81% in FY2024 (+84.28 pp), -385.08% in FY2023 (+85.72 pp), -470.80% in FY2022 (-37.61 pp) and -433.19% in FY2021 (-179.75 pp).
  • Five-year quarterly EBITDA Margin spans a low of -618.05% in Q2 2025 and a high of -121.47% in Q4 2025.
  • Year over year, EBITDA Margin has now increased in each of the last four quarters, with an average year-over-year change of +83.20 percentage points over the last six quarters.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -148.42% (Q1 2026), -121.47% (Q4 2025) and -165.74% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn 21.86%
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn 41.08%
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn 25.55%
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn 29.67%
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn 28.17%
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn 24.62%
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn 31.93%
10 Profound Medical 206.65 Mn 33.54 Mn 1.95 Mn -440.23%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -440.23%
Mar 31, 2026 -148.42%
Dec 31, 2025 -121.47%
Sep 30, 2025 -165.74%
Jun 30, 2025 -618.05%
Mar 31, 2025 -419.80%
Dec 31, 2024 -194.13%
Sep 30, 2024 -310.17%
Jun 30, 2024 -340.71%
Mar 31, 2024 -530.02%
API Access

Profound Medical EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PROF&period=max&api_key=YOUR_API_KEY